American Society of Hematology

Fig. 3.

$Fig. 3. Mean life and fractional increase for RESA-RBC. / The log RESA-RBC mean life (upper) is shorter and the RESA-RBC fractional increase between admission and 24 hours (lower) is higher for patients treated with an artemisinin derivative than for patients treated with quinine. Median, 10th, 25th, 75th, and 90th percentiles and outliers are shown.$

Mean life and fractional increase for RESA-RBC.

The log RESA-RBC mean life (upper) is shorter and the RESA-RBC fractional increase between admission and 24 hours (lower) is higher for patients treated with an artemisinin derivative than for patients treated with quinine. Median, 10th, 25th, 75th, and 90th percentiles and outliers are shown.

This Feature Is Available To Subscribers Only